SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-16-000131
Filing Date
2016-05-05
Accepted
2016-05-05 08:04:16
Documents
17
Period of Report
2016-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alimera8-k.htm 8-K 31019
2 EXHIBIT 99.1 pressrelease.htm EX-99.1 197288
3 EXHIBIT 99.2 presentation.htm EX-99.2 11474
4 image0a03.jpg GRAPHIC 18139
5 presentation001.jpg GRAPHIC 110692
6 presentation002.jpg GRAPHIC 385233
7 presentation003.jpg GRAPHIC 153578
8 presentation004.jpg GRAPHIC 103862
9 presentation005.jpg GRAPHIC 127000
10 presentation006.jpg GRAPHIC 118190
11 presentation007.jpg GRAPHIC 98797
12 presentation008.jpg GRAPHIC 58232
13 presentation009.jpg GRAPHIC 141035
14 presentation010.jpg GRAPHIC 134794
15 presentation011.jpg GRAPHIC 54861
16 presentation012.jpg GRAPHIC 133519
17 presentation013.jpg GRAPHIC 105934
  Complete submission text file 0001267602-16-000131.txt   2550543
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 6789905740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 161621640
SIC: 2834 Pharmaceutical Preparations